These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways. Piedimonte G; King KA; Holmgren NL; Bertrand PJ; Rodriguez MM; Hirsch RL Pediatr Res; 2000 Mar; 47(3):351-6. PubMed ID: 10709734 [TBL] [Abstract][Full Text] [Related]
11. Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal Antibody That Provides Greater Zhao M; Zheng ZZ; Chen M; Modjarrad K; Zhang W; Zhan LT; Cao JL; Sun YP; McLellan JS; Graham BS; Xia NS J Virol; 2017 Aug; 91(15):. PubMed ID: 28539438 [TBL] [Abstract][Full Text] [Related]
12. Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model. Caidi H; Miao C; Thornburg NJ; Tripp RA; Anderson LJ; Haynes LM Antiviral Res; 2018 Jun; 154():149-157. PubMed ID: 29678551 [TBL] [Abstract][Full Text] [Related]
13. Resveratrol suppresses persistent airway inflammation and hyperresponsivess might partially via nerve growth factor in respiratory syncytial virus-infected mice. Zang N; Li S; Li W; Xie X; Ren L; Long X; Xie J; Deng Y; Fu Z; Xu F; Liu E Int Immunopharmacol; 2015 Sep; 28(1):121-8. PubMed ID: 26044349 [TBL] [Abstract][Full Text] [Related]
14. MMP-12-mediated by SARM-TRIF signaling pathway contributes to IFN-γ-independent airway inflammation and AHR post RSV infection in nude mice. Long X; Li S; Xie J; Li W; Zang N; Ren L; Deng Y; Xie X; Wang L; Fu Z; Liu E Respir Res; 2015 Feb; 16(1):11. PubMed ID: 25652021 [TBL] [Abstract][Full Text] [Related]
15. Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection. Ríos AM; Mejías A; Chávez-Bueno S; Fonseca-Aten M; Katz K; Hatfield J; Gómez AM; Jafri HS; McCracken GH; Ramilo O; Hardy RD Antimicrob Agents Chemother; 2004 Aug; 48(8):2897-904. PubMed ID: 15273098 [TBL] [Abstract][Full Text] [Related]
16. Preparation and Evaluation of the Fully Humanized Monoclonal Antibody GD-mAb Against Respiratory Syncytial Virus. Tian P; Wang Y; Liu H; Yang Y; Wu X; Wei H; Chen T Front Cell Infect Microbiol; 2019; 9():275. PubMed ID: 31417879 [TBL] [Abstract][Full Text] [Related]
17. Effects of anti-g and anti-f antibodies on airway function after respiratory syncytial virus infection. Han J; Takeda K; Wang M; Zeng W; Jia Y; Shiraishi Y; Okamoto M; Dakhama A; Gelfand EW Am J Respir Cell Mol Biol; 2014 Jul; 51(1):143-54. PubMed ID: 24521403 [TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus infections: old challenges and new opportunities. Mejías A; Chávez-Bueno S; Jafri HS; Ramilo O Pediatr Infect Dis J; 2005 Nov; 24(11 Suppl):S189-96, discussion S196-7. PubMed ID: 16378045 [TBL] [Abstract][Full Text] [Related]
19. CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness. Schwarze J; Cieslewicz G; Joetham A; Ikemura T; Hamelmann E; Gelfand EW J Immunol; 1999 Apr; 162(7):4207-11. PubMed ID: 10201948 [TBL] [Abstract][Full Text] [Related]
20. Aerosol Delivery of Palivizumab in a Neonatal Lamb Model of Respiratory Syncytial Virus Infection. Edirisinghe HS; Rajapaksa AE; Royce SG; Sourial M; Bischof RJ; Anderson J; Sarila G; Nguyen CD; Mulholland K; Do LAH; Licciardi PV Viruses; 2023 Nov; 15(11):. PubMed ID: 38005952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]